The aim of our study was to investigate the relationship between myocardial sympathetic degeneration and nigrostriatal impairment in patients affected by Parkinson's disease (PD) by means of (123)I-metaiodobenzylguanidine ((123)I MIBG) scintigraphy and N-(3-fluoropropyl)-2β-carbomethoxy-3β-(4-[(123)I]iodophenyl)nortropane ((123)I FP-CIT) scintigraphy.
Chiaravalloti, A., Stefani, A., Di Biagio, D., Pierantozzi, M., Tavolozza, M., Di Pietro, B., et al. (2013). Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease. ANNALS OF NUCLEAR MEDICINE, 27(5), 444-451 [10.1007/s12149-013-0702-z].
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease
CHIARAVALLOTI, AGOSTINO;STEFANI, ALESSANDRO;PIERANTOZZI, MARIANGELA;TAVOLOZZA, MARIO;STANZIONE, PAOLO;SCHILLACI, ORAZIO
2013-06-01
Abstract
The aim of our study was to investigate the relationship between myocardial sympathetic degeneration and nigrostriatal impairment in patients affected by Parkinson's disease (PD) by means of (123)I-metaiodobenzylguanidine ((123)I MIBG) scintigraphy and N-(3-fluoropropyl)-2β-carbomethoxy-3β-(4-[(123)I]iodophenyl)nortropane ((123)I FP-CIT) scintigraphy.| File | Dimensione | Formato | |
|---|---|---|---|
|
ann nucl med .pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
255.91 kB
Formato
Adobe PDF
|
255.91 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
ann nucl med .pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
255.91 kB
Formato
Adobe PDF
|
255.91 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
